In addition, OGT silencing inhibits tumor growth in different models including breast cancer, prostate cancer, and pancreatic cancer (34, 37, 38), indicating that O-GlcNAcylation is important for tumorigenesis and suggesting that OGT represents a novel therapeutic target for these types of cancers (39). This evidence concerns the gene OGT and Familial prostate cancer.